About the Authors
- Pablo D. Becker
-
Contributed equally to this work with: Pablo D. Becker, Nicolas Legrand
Affiliation Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
- Nicolas Legrand
-
Contributed equally to this work with: Pablo D. Becker, Nicolas Legrand
Affiliation Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam (AMC-UvA), Center for Immunology Amsterdam (CIA), Amsterdam, The Netherlands
- Caroline M. M. van Geelen
-
Affiliation AIMM Therapeutics, Amsterdam, The Netherlands
- Miriam Noerder
-
Affiliation Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
- Nicholas D. Huntington
-
Affiliations Cytokines and Lymphoid Development Unit, Institut Pasteur, Paris, France, INSERM U668, Institut Pasteur, Paris, France
- Annick Lim
-
Affiliation INSERM U668, Institut Pasteur, Paris, France
- Etsuko Yasuda
-
Current address: Department of Medicine, University of Vermont, Burlington, Vermont, United States of America
Affiliation AIMM Therapeutics, Amsterdam, The Netherlands
- Sean A. Diehl
-
Current address: Department of Medicine, University of Vermont, Burlington, Vermont, United States of America
Affiliation Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam (AMC-UvA), Center for Immunology Amsterdam (CIA), Amsterdam, The Netherlands
- Ferenc A. Scheeren
-
Current address: Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, California, United States of America
Affiliation Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam (AMC-UvA), Center for Immunology Amsterdam (CIA), Amsterdam, The Netherlands
- Michael Ott
-
Affiliation Clinic for Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Twincore Centre of Experimental and Clinical Infection Research, Hannover, Germany
- Kees Weijer
-
Affiliation Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam (AMC-UvA), Center for Immunology Amsterdam (CIA), Amsterdam, The Netherlands
- Heiner Wedemeyer
-
Affiliation Clinic for Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Twincore Centre of Experimental and Clinical Infection Research, Hannover, Germany
- James P. Di Santo
-
Affiliations Cytokines and Lymphoid Development Unit, Institut Pasteur, Paris, France, INSERM U668, Institut Pasteur, Paris, France
- Tim Beaumont
-
Affiliation AIMM Therapeutics, Amsterdam, The Netherlands
- Carlos A. Guzman
-
Affiliation Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
- Hergen Spits
-
* E-mail: Hergen.Spits@amc.uva.nl
Affiliations Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam (AMC-UvA), Center for Immunology Amsterdam (CIA), Amsterdam, The Netherlands, AIMM Therapeutics, Amsterdam, The Netherlands
Competing Interests
F.A.S., S.A.D., T.B. and H.S. are listed on a patent application describing the BCL6/BCL-XL technology developed by AIMM Therapeutics. C.M.M.v.G., E.Y., T.B. and H.S. are employees of AIMM Therapeutic. The employees of AIMM Therapeutics all have equity interest. H.S. has personal financial interests in AIMM Therapeutics. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have no conflicting financial interests.
Author Contributions
Conceived and designed the experiments: PDB NL CMMvG. Performed the experiments: PDB NL CMMvG MN NH AL EY SAD FAS. Analyzed the data: PDB NL CMMvG NH AL MO HW JPDS TB CAG HS. Contributed reagents/materials/analysis tools: KW. Wrote the paper: PDB NL CMMvG NH JPDS TB CAG HS.